JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB8329

Anti-EBV Nuclear Antigen/EBNA1 抗体 [E1-2.5]

Anti-EBV Nuclear Antigen/EBNA1 antibody [E1-2.5]

Be the first to review this product! Submit a review

|

(9 Publications)

Mouse Monoclonal EBV Nuclear Antigen/EBNA1 antibody. Suitable for ICC, ELISA, IHC-P and reacts with Epstein-Barr virus samples. Cited in 9 publications. Immunogen corresponding to Synthetic Peptide within Epstein-Barr Virus (Strain B95-8) EBNA1.

查看别名

BKRF1, EBNA1, Epstein-Barr nuclear antigen 1, EBNA-1, EBV nuclear antigen 1

关键信息

宿主种属

Mouse

克隆

Monoclonal

克隆号

E1-2.5

亚型

IgG2b

不含载体蛋白

No

反应种属

Epstein-Barr virus

应用

IHC-P, ICC, ELISA

applications

免疫原

Synthetic Peptide within Epstein-Barr Virus (Strain B95-8) EBNA1. The exact immunogen used to generate this antibody is proprietary information.

P03211

特异性

Recognizes repetitive gly-ala region of the nuclear antigen 1 of Epstein Barr virus (EBNA-1).

反应性数据

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ICC" : {"fullname" : "Immunocytochemistry", "shortname":"ICC"}, "ELISA" : {"fullname" : "ELISA", "shortname":"ELISA"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Epstein-Barr virus": { "ICC-species-checked": "guaranteed", "ICC-species-dilution-info": "", "ICC-species-notes": "<p></p>", "ELISA-species-checked": "guaranteed", "ELISA-species-dilution-info": "", "ELISA-species-notes": "<p></p>", "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>" } } }

性能和储存信息

形式
Liquid
纯化工艺
Affinity purification Protein A
存储溶液
pH: 7.4 Preservative: 0.097% Sodium azide Constituents: PBS
运输条件
Blue Ice
推荐的短期储存时间
1-2 weeks
推荐的短期储存条件
+4°C
推荐的长期储存条件
-20°C
分装信息
Upon delivery aliquot
储存信息
Avoid freeze / thaw cycle

补充信息

This supplementary information is collated from multiple sources and compiled automatically.

EBV Nuclear Antigen 1 (EBNA1) is a protein expressed by the Epstein-Barr Virus (EBV) also known as Human Herpesvirus 4. It has a molecular weight of approximately 80 kDa and shows expression in latently infected cells. EBNA1 acts as a viral episome-maintenance protein that binds to the EBV genome ensuring viral DNA replication and partitioning during cell division. This protein facilitates the persistent infection of EBV in host cells. Occasionally it is also referred to as EBV EBNA or EBNA-1 protein.
Biological function summary

EBNA1 functions as an EBV-specific DNA-binding protein essential for maintaining the viral episome within infected cells. EBNA1 plays a role in gene regulation by interacting with specific DNA sequences called oriP to assist in the replication and maintenance of the viral DNA. It does not form part of a larger protein complex but strongly influences cellular processes through these interactions. EBNA1 ensures the survival and propagation of the virus without immediate cytopathic effects contributing to its long-term persistence.

Pathways

EBNA1 is central to viral latency and replication pathways in host cells. EBNA1 influences both the EBV lytic and latent cycles maintaining the latency by stabilizing the viral episome within the nucleus of host cells and regulating viral gene expression. It interacts with cellular proteins like USP7 a deubiquitinase important for the regulation of EBNA1 stability and function. These pathways highlight EBNA1's role in the balance between viral latency and active replication.

EBNA1 is closely associated with several EBV-related cancers such as Burkitt's lymphoma and nasopharyngeal carcinoma. The persistent expression of EBNA1 contributes to oncogenic processes by disrupting normal cellular control mechanisms. EBNA1's interaction with p53 a tumor suppressor protein can interfere with the host's cell-cycle regulation and apoptosis allowing for malignant transformation. These interactions illustrate EBNA1's significant role in the pathogenesis of disorders linked to EBV infection.

产品实验方案

For this product, it's our understanding that no specific protocols are required. You can visit:

靶点信息

Responsible for the origin of replication (oriP) dependent replication and maintenance of viral episomes during latent infection (PubMed : 15479791, PubMed : 2996781). EBNA1 dimer interacts with the DS (dyad symmetry) element within the origin of replication oriP and with a host mitotic chromosome to initiate viral DNA replication during latency (PubMed : 24067969, PubMed : 2996781, PubMed : 31142669, PubMed : 8551585). EBNA1 binding to DS recruits the host origin recognition complex (ORC) (PubMed : 12953058). Governs the faithful mitotic segregation of the viral episomes by binding both the FR (family of repeats) element within oriP and the host mitotic chromosomes (PubMed : 11172042, PubMed : 15479791, PubMed : 24067969). Forms a cell cycle-dependent tyrosine-dependent DNA cross-link and single-strand cleavage at oriP required for terminating replication and maintaining viral episomes (PubMed : 33482082). Counteracts the stabilization of host p53/TP53 by host USP7, thereby decreasing apoptosis and increasing host cell survival (PubMed : 15808506). Induces degradation of host PML through the ubiquitin-proteasome system, which promotes lytic reactivation and may impair the host cell DNA repair (PubMed : 18833293). Increases the association of CK2 with PML proteins which increases the phosphorylation of PML proteins by CK2, triggering the polyubiquitylation and degradation of PML (PubMed : 20719947). Displays inhibitory effects on a SUMO2-modified complex that includes STUB1, KAP1 and USP7 (PubMed : 32176739). This inhibitory effect possibly participates to the maintenance of latency linked to PML silencing (PubMed : 32176739).
See full target information EBNA1

文献 (9)

Recent publications for all applications. Explore the full list and refine your search

Frontiers in cellular and infection microbiology 13:1270935 PubMed37928187

2023

Co-infection and co-localization of Kaposi sarcoma-associated herpesvirus and Epstein-Barr virus in HIV-associated Kaposi sarcoma: a case report.

Applications

Unspecified application

Species

Unspecified reactive species

Peter Julius,Guobin Kang,Stepfanie Siyumbwa,Jane Musumali,For Yue Tso,Owen Ngalamika,Trevor Kaile,Fred Maate,Phyllis Moonga,John T West,Peter Angeletti,Charles Wood

Frontiers in oncology 12:864066 PubMed35494029

2022

Epstein-Barr Virus, But Not Human Papillomavirus, Is Associated With Preinvasive and Invasive Ocular Surface Squamous Neoplasias in Zambian Patients.

Applications

Unspecified application

Species

Unspecified reactive species

Peter Julius,Stepfanie N Siyumbwa,Phyllis Moonga,Fred Maate,Trevor Kaile,Gleb Haynatski,Veenu Minhas,Jazmine Snow,Kerstin Peterson,Patience Gihozo,Sam Streeter,Salan Kaur,Annika Evans,Daniela Gonzalez,Kandali Samwel,Guobin Kang,John T West,Charles Wood,Peter C Angeletti

Cell death & disease 9:734 PubMed29959331

2018

The Hsp70 inhibitor 2-phenylethynesulfonamide inhibits replication and carcinogenicity of Epstein-Barr virus by inhibiting the molecular chaperone function of Hsp70.

Applications

Unspecified application

Species

Unspecified reactive species

Huan Wang,Lang Bu,Chao Wang,Yaqian Zhang,Heng Zhou,Xi Zhang,Wei Guo,Cong Long,Deyin Guo,Xiaoping Sun

Oncology reports 37:2109-2120 PubMed28259949

2017

Berberine inhibits the proliferation of human nasopharyngeal carcinoma cells via an Epstein-Barr virus nuclear antigen 1-dependent mechanism.

Applications

Unspecified application

Species

Unspecified reactive species

Chao Wang,Huan Wang,Yaqian Zhang,Wei Guo,Cong Long,Jingchao Wang,Limei Liu,Xiaoping Sun

Cell research 25:785-800 PubMed25916549

2015

In-cell infection: a novel pathway for Epstein-Barr virus infection mediated by cell-in-cell structures.

Applications

Unspecified application

Species

Unspecified reactive species

Chao Ni,Yuhui Chen,Musheng Zeng,Rongjuan Pei,Yong Du,Linquan Tang,Mengyi Wang,Yazhuo Hu,Hanyu Zhu,Meifang He,Xiawei Wei,Shan Wang,Xiangkai Ning,Manna Wang,Jufang Wang,Li Ma,Xinwen Chen,Qiang Sun,Hong Tang,Ying Wang,Xiaoning Wang

PloS one 5:e8692 PubMed20098683

2010

The synthesis of truncated polypeptides for immune surveillance and viral evasion.

Applications

Unspecified application

Species

Unspecified reactive species

Sylvain Cardinaud,Shelley R Starck,Piyanka Chandra,Nilabh Shastri

Clinical biochemistry 41:486-92 PubMed18258188

2008

Detection of Epstein-Barr virus in breast carcinoma in Egyptian women.

Applications

IHC-P

Species

Unspecified reactive species

Shereen Fawzy,Maha Sallam,Nahla Mohammad Awad

Blood 110:1123-31 PubMed17468341

2007

Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial.

Applications

IHC-P

Species

Unspecified reactive species

Tanzina Haque,Gwen M Wilkie,Marie M Jones,Craig D Higgins,Gillian Urquhart,Phoebe Wingate,David Burns,Karen McAulay,Marc Turner,Christopher Bellamy,Peter L Amlot,Deirdre Kelly,Alastair MacGilchrist,Maher K Gandhi,Anthony J Swerdlow,Dorothy H Crawford

Arthritis and rheumatism 54:360-8 PubMed16385527

2005

An altered immune response to Epstein-Barr nuclear antigen 1 in pediatric systemic lupus erythematosus.

Applications

Unspecified application

Species

Unspecified reactive species

Micah T McClain,Brian D Poole,Benjamin F Bruner,Kenneth M Kaufman,John B Harley,Judith A James
View all publications

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂,为您科研的每一步提供支持。若我们的产品未能达到预期性能,我们向您提供 Abcam Product Promise 保障。
详情请参阅我们的条款与条件。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com